[1] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015. CA-Cancer J Clin 2016; 66(2): 115–132.
[2] McCorkle R, Ercolano E, Lazenby M, et al. Self-management: Enabling and empowering patients living with cancer as a chronic illness. CA Cancer J Clin 2011; 61(1):50-62.
[3] Rutter M. Resilience in the face of adversity: Protective factors and resistance to psychiatric disorder. Brit J Psychiatry 1985; 147(6):598-611.
[4] Ye ZJ, Qiu HZ, Li PF, et al. Predicting changes in quality of life and emotional distress in Chinese patients with lung, gastric, and colon-rectal cancer diagnoses: the role of psychological resilience. Psycho-oncology 2017; 26(6):829-835.
[5] Luo D, Eicher M, White K. Individual resilience in adult cancer care: A concept analysis. Int J Nurs Stud. 2020, 102:103467. Epub ahead of print. Doi: 10.1016/j.ijnurstu.2019.103467.
[6] Ye ZJ, Liang MZ, Li PF, et al. New resilience instrument for patients with cancer. Qual Life Res 2018; 27(2):355-365.
[7] Ye ZJ, Peng CH, Zhang HW, et al. A Biopsychosocial Model of Resilience for Breast Cancer: A Preliminary Study in Mainland China. Eur J Oncol Nurs 2018; 36:95-102.
[8] Ye ZJ, Liang MZ, Zhang HW, et al. Psychometric Properties of the Chinese Version of Resilience Scale Specific to Cancer: An Item Response Theory Analysis. Qual Life Res 2018; 27(6):1635-1645.
[9] Ye ZJ, Zhang Z, Tang Y, et al. Development and psychometric analysis of the 10-item resilience scale specific to cancer: A multidimensional item response theory analysis. Eur J Oncol Nurs, 2019, 41:64-71.
[10] Revicki D, Hays RD, et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008; 61(2): 102-109
[11] Turner D, Schünemann HJ, Griffith LE, et al. The minimal detectable change cannot reliably replace the minimal important difference. J Clin Epidemiol 2010; 63(1):28-36.
[12] Ye ZJ, Qiu HZ, Liang MZ, et al. Effect of a mentor-based, supportive-expressive program, Be Resilient to Breast Cancer, on survival in metastatic breast cancer—A randomized, controlled intervention trial. Br J Cancer 2017; 117(10):1486-1494.
[13] Ye ZJ, Liang MZ, Qiu HZ, et al. Effect of a multidiscipline mentor-based program, Be Resilient to Breast Cancer (BRBC), on female breast cancer survivors in mainland China-A randomized, controlled, theoretically-derived intervention trial. Breast Cancer Res Treat 2016; 158(3):509-522.
[14] Ye ZJ, Zhang Z, Zhang XY, et al. Effectiveness of adjuvant supportive-expressive group therapy for breast cancer. Breast Cancer Res Tr 2020; 180(1):121-134.
[15] Ye ZJ, Zhang Z, Zhang XY, et al. State or trait? Measuring resilience by generalisability theory in breast cancer. Eur J Oncol Nurs, 2020, 46:101727.
[16] EORTC Quality of Life Group. Quality of life research within the EORTC—the EORTC QLQ-C30. Eur J Cancer 2002; 38(4):125-133.
[17] Wan CH, Chen MQ, Zhang CZ, et al. The introduction of the Chinese version of EORTC QLQ-C30 in patients with cancer. J Pract Oncol 2005; 4:353-355.
[18] Yu XN, Zhang JX. Factor analysis and psychometric evaluation of the Connor-Davidson Resilience Scale (CD-RISC) with Chinese people. Soc Behav Pers 2007; 35(1):19-31.
[19] Ye ZJ, Qiu HZ, Li PF, et al. Validation and Application of the Chinese Version of the 10-item Connor-Davidson Resilience Scale (CD-RISC-10) among Parents of Children with Cancer Diagnosis. Eur J Oncol Nurs 2017; 27:36-44
[20] Ni MY, Li TK, Yu NX, et al. Normative data and psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) and the abbreviated version (CD-RISC2) among the general population in Hong Kong. Qual Life Res 2016; 25(1):111-116.
[21] Li Q, Lin Y, Hu C, et al. The Chinese version of hospital anxiety and depression scale: Psychometric properties in Chinese cancer patients and their family caregivers. Eur J Oncol Nurs 2016; 25:16-23.
[22] Seeman TE, McEwen BS, Rowe JW, et al. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci USA 2001; 98:4770-4775.
[23] Karlamangla AS, Singer BH, Seeman TE. Reduction in allostatic load in older adults is associated with lower all-cause mortality risk: MacArthur studies of successful aging. Psychosom Med 2006; 68:500-507.
[24] Qiu HZ, Ye ZJ, Liang MZ, et al. Effect of an art brut therapy program, go beyond the schizophrenia (GBTS),on prison inmates with schizophrenia in mainland China-A randomized, longitudinal, and controlled trial. Clin. Psychol. Psychother. 2017; 24(5):1069-1078.
[25] Ye ZJ, Cai RQ, Liu ML, et al. The development of the Transitional Care Model in nursing in mainland China: A literature review. Int J Nurs Sci. 2016, 3(1):113-130.
[26] DeVellis, RF. Scale development : theory and applications. Thousand Oaks, Calif.SAGE,2012.
[27] Polit DF, Beck CT. Essentials of nursing research: appraising evidence for nursing practice. Philadelphia: Wolters Kluwer Health, 2018.
[28] Hawkins DL. Using U Statistics to Derive the Asymptotic Distribution of Fisher's Z Statistic, Am Stat 1989; 43(4):235-237.
[29] Sokal RR, Rohlf FJ, Biometry. The principles and practice of statistics in biological research. 3rd edition. New York: WH Freeman, 1995.
[30] Cohen J. Statistical power analysis for the behavioral sciences, 2nd edn. Lawerence Erlbaum Associates, Inc., Hillsdale,1988.
[31] Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41:582-592.
[32] Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 1999; 52: 861-873.
[33] Raman S, Ding K, Chow E, et al. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases. Qual Life Res 2018; 27(4):1089-1098.
[34] Ye ZJ, Wang ZY, Yu YL, Liang MZ, et al. Reliability and Validity of the Chinese Version of the 10-item Connor-Davidson Resilience Scale in Chinese Cancer Patients.Chin Gen Pract 2018; 21(15):1839-1844.
[35] Smid DE, Franssen FM, Houben-Wilke S, et al. Responsiveness and MCID Estimates for CAT, CCQ, and HADS in Patients With COPD Undergoing Pulmonary Rehabilitation: A Prospective Analysis. J Am Med Dir Assoc 2017; 18(1):53-58.
[36] Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3(1):32-35.
[37] Zar JH. Biostatistical Analysis. Fifth Edition. Prentice-Hall. Englewood Cliffs, New Jersey, 2009.
[38] Kon SS, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med 2014; 2:195-203.
[39] Copay AG, Subach BR, Glassman SD, et al. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 2007; 7:541–546.
[40] Schunemann HJ, Griffith L, Jaeschke R, et al. Evaluation of the minimal important difference for the feeling thermometer and the St. George’s Respiratory Questionnaire in patients with chronic air flow obstruction. J Clin Epidemiol 2003; 56:1170-1176.
[41] Puhan MA, Chandra D, Mosenifar Z, et al. The minimal important difference of exercise tests in severe COPD. Eur Respir J 2011; 37:784-790.
[42] Ye ZJ, Qiu HZ, Li PF, et al. Resilience model for parents of children with cancer in mainland China-An exploratory study. Eur J Oncol Nurs, 2017, 27:9-16.
[43] Ye ZJ, Liu ML, Zhang Z, et al. Psychometric properties of the Chinese version of the Parent Perception of Uncertainty Scale (PPUS) among parents of children with cancer diagnosis. Intl J Nurs Sci, 2017, 4(3):278-284.
[44] Rosenberg AR, Bradford MC, Junkins CC, et al. Effect of the Promoting Resilience in Stress Management Intervention for Parents of Children With Cancer (PRISM-P): A Randomized Clinical Trial. JAMA Netw Open 2019; 2(9):e1911578.
[45] Yi-Frazier JP, Fladeboe K, Klein V, et al. Promoting Resilience in Stress Management for Parents (PRISM-P): An intervention for caregivers of youth with serious illness. Fam Syst Health 2017; 35(3):341-351.
[46] Ye ZJ, Zhang Zhang, Liang MZ, et al. Symptoms and management of children with incurable cancer in mainland China. Eur J Oncol Nurs, 2019, 38:42-49.
[47] Rosenberg AR, Bradford MC, McCauley E, Curtis JR, Wolfe J, Baker KS, Yi-Frazier JP. Promoting resilience in adolescents and young adults with cancer: Results from the PRISM randomized controlled trial. Cancer 2018; 124(19):3909-3917.
[48] Ye ZJ, Cheng MH, Zhang XY, et al. Treatment Decision-Making and Regret in Parents of Children with Incurable Cancer. Cancer Nurs, 2019, online, doi:10.1097/NCC.0000000000000783.
[49] Ye ZJ, Guan HJ, Wu LH, et al. The resilience and psychosocial function among mainland Chinese parents of children with cancer: a cross-sectional survey. Cancer Nurs, 2015, 38(6): 466-474.
[50] Ye ZJ, Zhang XY, Liang J, et al. The Challenges of Medical Ethics in China: Are Gene-Edited Babies Enough? Sci Eng Ethics, 2020, 26(1):123-125.